Tuberkuloz ve Toraks (Tuberculosis and Thorax) is a distinguished journal published by the TURKISH ASSOCIATION OF TUBERCULOSIS AND THORAX located in Turkey. Serving as a pivotal platform for researchers and practitioners in the fields of Critical Care, Intensive Care Medicine, and Pulmonary and Respiratory Medicine, this journal has been disseminating vital research since 2003 and is committed to advancing knowledge and clinical practices related to tuberculosis and thoracic diseases. Although currently not an Open Access publication, its relevance is underscored by its rankings within Scopus, including a Q3 category in Critical Care and Intensive Care Medicine and a Q4 in Pulmonary and Respiratory Medicine, reflecting its significant contributions to the academic community. With a mission to foster the exchange of innovative ideas and encourage rigorous scholarly discourse, Tuberkuloz ve Toraks plays an essential role in addressing pressing health challenges associated with respiratory ailments and remains an invaluable resource for researchers, health professionals, and students dedicated to improving outcomes in thoracic health.

The Netherlands Journal of Critical Care, an esteemed publication of the NETHERLANDS SOC INTENSIVE CARE, serves as a vital resource for those in the fields of critical care and intensive medicine. As a platform focused on disseminating high-quality research from 2008 to 2023, this journal provides critical insights and advancements pertinent to the rapidly evolving landscape of intensive care practices. Though categorized in the fourth quartile for Critical Care and Intensive Care Medicine in 2023, its commitment to enhancing patient outcomes remains unwavering. With an ISSN of 1569-3511, this journal invites submissions that push the boundaries of knowledge and offer innovative approaches to critical care challenges. Thus, it is an essential reference for researchers, healthcare professionals, and students eager to stay at the forefront of critical care developments in the Netherlands and beyond.

Current Opinion in Critical Care, published by Lippincott Williams & Wilkins, is a leading journal in the field of Critical Care and Intensive Care Medicine. With an ISSN of 1070-5295 and an E-ISSN of 1531-7072, this esteemed journal has been committed to disseminating high-quality and impactful research since its inception in 1996. The journal proudly ranks in the top quartile (Q1) of its category for 2023, affirming its position among the premier publications in critical care, with a Scopus ranking of #25 out of 110, placing it in the 77th percentile. Current Opinion in Critical Care offers essential insights, reviews, and discussions on the latest trends and best practices in the field, catering to the needs of researchers, clinicians, and students alike. Though it does not provide open access options, its contributions are pivotal in shaping patient care approaches and advancing clinical outcomes in critical care settings.

The Journal of Intensive Care, published by BMC, is a leading open access journal dedicated to advancing research and knowledge in the fields of critical care and intensive care medicine. With an impressive 2023 rank of #11 out of 110 in its category and placing in the 90th percentile, this journal offers a vital platform for researchers, clinicians, and healthcare professionals to disseminate innovative findings and best practices. Launched in 2013, the journal has gained significant recognition, achieving a Q1 quartile ranking in critical care, reflecting its commitment to high-quality contributions that address pressing issues in patient management and care. Additionally, as an open access publication, the journal ensures that its content is widely accessible, fostering collaboration and knowledge sharing within the global medical community. For those engaged in intensive care, the Journal of Intensive Care is an essential resource for staying abreast of the latest research trends and clinical advancements.

Signa Vitae is a distinguished academic journal published by MRE PRESS, focusing on critical care, intensive care medicine, and emergency medicine. Established in 2008 and running through 2024, this journal serves as an essential conduit for the dissemination of innovative research and clinical practices in these dynamic fields. Based in Croatia, Signa Vitae is indexed in Scopus, highlighting its importance within the scholarly community, boasting respectable quartiles with a Q3 ranking in both Critical Care and Intensive Care Medicine and Emergency Medicine as of 2023. Although it operates under a traditional access model, the journal aims to enhance knowledge sharing and interdisciplinary dialogue among researchers, healthcare professionals, and students globally, addressing the urgent challenges and advancements in patient care. By providing a platform for high-quality studies and reviews, Signa Vitae continues to advance the conversation and practice within critical and emergency medicine.

Journal of Acute Disease is a leading peer-reviewed publication dedicated to the timely dissemination of research focused on acute medical conditions, enhancing our understanding and management of these vital health issues. Published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, this Open Access journal has been committed to providing unrestricted access to high-quality research since its establishment in 2012, ensuring that professionals, researchers, and students can readily benefit from groundbreaking studies and innovative practices in the field. With a focus on enhancing clinical practice through rigorous research, the journal covers a wide range of topics including epidemiology, diagnostics, treatment protocols, and patient outcomes related to acute diseases. With its robust editorial team and a global readership, the Journal of Acute Disease serves as an essential platform for advancing knowledge and improving healthcare delivery worldwide.

Sarcoidosis Vascularitis and Diffuse Lung Diseases is a prestigious academic journal published by Mattioli 1885, focusing on the interdisciplinary study of sarcoidosis, vasculitis, and various diffuse lung diseases. Since its inception in 1996, this journal has been pivotal in disseminating vital research findings, clinical experiences, and comprehensive reviews related to these complex conditions, supporting health professionals and researchers in advancing their understanding and treatment approaches. With a convergence period extending to 2024, the journal has gained recognition in multiple categories, including Q4 in Immunology and Allergy, and Q3 rankings in Internal Medicine, Medicine (Miscellaneous), and Pulmonary and Respiratory Medicine, reflecting its commitment to high-quality and impactful studies. Although currently not offering open access, its contributions are indispensable for the academic community, making it a vital resource for those dedicated to improving patient outcomes and fostering knowledge in the field.

CRITICAL CARE MEDICINE is a premier journal dedicated to the advancement of knowledge and practice in the field of critical care and intensive care medicine. Published by Lippincott Williams & Wilkins, this distinguished journal has been at the forefront of medical research since its inception in 1973, and it continues to offer insights into the latest developments and innovations in critical care. With a remarkable ranking of #5 out of 110 in Scopus' Critical Care category and a 95th percentile rating, CRITICAL CARE MEDICINE is a leading source for high-impact research, reviews, and clinical studies. The journal is recognized as a Q1 publication, underscoring its authoritative presence within the academic community. Researchers and clinicians are encouraged to engage with cutting-edge findings that aim to improve patient care and outcomes. Although the journal is not open access, it remains an essential resource for professionals seeking to enhance their understanding and application of critical care practices.

Hepatic Medicine-Evidence and Research is a distinguished open-access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing knowledge in the field of hepatology. Since its inception in 2009, this journal has served as a critical platform for researchers, professionals, and students alike, facilitating the dissemination of high-quality, peer-reviewed articles that address the latest developments in hepatic medicine. With a commitment to accessibility, all articles are freely available to a global audience, thereby promoting collaboration and innovation in research. Although specific metrics such as H-index and Scopus ranks are currently undeclared, the journal is recognized for its contributions to clinical practice and ongoing research in liver health, making it an essential resource for those seeking to enhance their understanding of hepatic conditions and treatments. By prioritizing the latest evidence and research in this vital field, Hepatic Medicine-Evidence and Research continues to play a pivotal role in influencing clinical outcomes and shaping future studies.

The Canadian Respiratory Journal is a prominent peer-reviewed publication dedicated to advancing knowledge in the field of pulmonary and respiratory medicine. Published by HINDAWI LTD and based in Egypt, this journal has been an Open Access platform since 1994, ensuring broad dissemination of vital research findings to a global audience. With an ISSN of 1198-2241 and an E-ISSN of 1916-7245, the journal plays a significant role in shaping respiratory health discussions, evidenced by its 2023 category rankings of Q2 in Medicine (miscellaneous) and Q3 in Pulmonary and Respiratory Medicine. The journal consistently publishes high-quality research, reviews, and clinical guidelines that resonate with practitioners, researchers, and students alike. It serves as an essential resource for those seeking to stay at the forefront of developments in respiratory health, reflecting its commitment to enhancing practice and informing policy while recognizing its place in this vital medical field.